BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 8104031)

  • 1. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
    Bloom D; Krishnan B; Thavundayil JX; Lal S
    Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent chlorpromazine deposits in donor corneal tissue after corneal transplantation.
    Cahane M; Chen V; Avni I
    Cornea; 1997 Sep; 16(5):588-9. PubMed ID: 9294694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants].
    Panzitt M; Simon M; Weger M
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):273-5. PubMed ID: 11392274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corneal and lens deposits due to treatment by phenothiazine type neuroleptics].
    Pouget R; Blayac JP; Largey B; Alric R; Castelnau D; Boulet J
    Ann Med Psychol (Paris); 1976 Mar; 1(3):403-7. PubMed ID: 7987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 8. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of neuroleptics: state of the art.
    Simpson GM; Yadalam K
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual complications of antipsychotic drugs.
    Diamond JM; Santos AB
    Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.